A Prospective Clinical Registry Study of Genetic Profiling and Targeted Therapies in Patients With Rare Cancers in ASIA
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 18
- 主要终点
- Overall incidence of any genomic alteration in overall population
研究概览
简要总结
This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing.
The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with a histological diagnosis of rare cancer, cancer of unknown primary origin, or cancer of rare tissue subtypes of common cancers. (Defined in protocol.)
- •Patients with Advanced stage cancer.
排除标准
- •Patients with complications of cognitive impairment.
结局指标
主要结局
Overall incidence of any genomic alteration in overall population
时间窗: 1 year
Overall incidence of any genomic alteration in overall population
Overall incidence of any genomic alteration in patients with a certain cancer type
时间窗: 1 year
Overall incidence of any genomic alteration in patients with a certain cancer type
次要结局
- Incidence of individual genomic alteration in overall population(1 year)
- Incidence of individual genomic alteration in patients with a certain cancer type(1 year)